# Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy

> **NCT03713216** · PHASE4 · COMPLETED · sponsor: **Cathay General Hospital** · enrollment: 44 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Naldebain
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03713216
- **Lead sponsor:** Cathay General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03713216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03713216, "Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03713216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*